Ozturk, Tugba
Kollhoff, Alexander
Anderson, Albert M.
Christina Howell, J.
Loring, David W.
Waldrop-Valverde, Drenna
Franklin, Donald
Letendre, Scott
Tyor, William R.
Hu, William T. http://orcid.org/0000-0003-4862-6777
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (095679, 100999)
U.S. Department of Veterans Affairs (BX01506)
U.S. Department of Health & Human Services | NIH | National Institute on Aging (042856, 043885)
Article History
Received: 1 February 2019
Accepted: 6 June 2019
First Online: 19 June 2019
Competing Interests
: Ms. Ozturk, Mr. Kollhoff, Dr. Anderson, Ms. Howell Dr. Loring, Dr. Waldrop-Velverde, Dr. FranklinĀ and Dr. Tyor declare no competring interests. Dr. Letendre has consulted for GlaxoSmithKlein and received travel support from GlaxoSmithKlein, ViiV Healthcare Company, and Gilead Sciences. Dr. Hu has received grant support from Fujirebio US and Avid Radiopharmaceutical; has received travel support from Hoffman-LaRoche and Abbvie; has a patent on CSF-based diagnosis of neurodegenerative disorders (assigned to Emory University); consults for AARP Inc., ViveBio, LLC, Locks Law Firm, and Interpleader Law.